Company Filing History:
Years Active: 2021-2025
Title: Min-Ching Chung: Innovator in Receptor Interaction Research
Introduction
Min-Ching Chung is a notable inventor based in Taiwan. He has made significant contributions to the field of receptor interactions, particularly focusing on the interplay between estrogen receptors and cannabinoid receptors. His innovative work aims to enhance therapeutic applications and molecular imaging techniques.
Latest Patents
Min-Ching Chung holds a patent titled "Composition For Cross Talk Between Estrogen Receptors And Cannabinoid Receptors." This composition includes a chelator and a receptor ligand, facilitating cross talk between the two types of receptors. The patent also outlines a method for synthesizing this composition, which can be further developed into pharmaceutical formulations or kits for therapeutic use or molecular imaging.
Career Highlights
Throughout his career, Min-Ching Chung has focused on advancing the understanding of receptor interactions. His research has the potential to impact various therapeutic areas, particularly in hormone-related treatments and cannabinoid applications. Despite having 2 patents, his work remains influential in the scientific community.
Collaborations
Min-Ching Chung has collaborated with esteemed colleagues, including David J Yang and Wei-Chung Chang. These partnerships have contributed to the depth and breadth of his research, fostering innovation in receptor interaction studies.
Conclusion
Min-Ching Chung is a dedicated inventor whose research on receptor interactions holds promise for future therapeutic advancements. His contributions to the field continue to inspire further exploration and innovation.